Correlation Between Supernus Pharmaceuticals and Silver Spike
Can any of the company-specific risk be diversified away by investing in both Supernus Pharmaceuticals and Silver Spike at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Supernus Pharmaceuticals and Silver Spike into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Supernus Pharmaceuticals and Silver Spike Investment, you can compare the effects of market volatilities on Supernus Pharmaceuticals and Silver Spike and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Supernus Pharmaceuticals with a short position of Silver Spike. Check out your portfolio center. Please also check ongoing floating volatility patterns of Supernus Pharmaceuticals and Silver Spike.
Diversification Opportunities for Supernus Pharmaceuticals and Silver Spike
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Supernus and Silver is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Supernus Pharmaceuticals and Silver Spike Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silver Spike Investment and Supernus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Supernus Pharmaceuticals are associated (or correlated) with Silver Spike. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silver Spike Investment has no effect on the direction of Supernus Pharmaceuticals i.e., Supernus Pharmaceuticals and Silver Spike go up and down completely randomly.
Pair Corralation between Supernus Pharmaceuticals and Silver Spike
Given the investment horizon of 90 days Supernus Pharmaceuticals is expected to generate 2.61 times less return on investment than Silver Spike. In addition to that, Supernus Pharmaceuticals is 1.0 times more volatile than Silver Spike Investment. It trades about 0.2 of its total potential returns per unit of risk. Silver Spike Investment is currently generating about 0.51 per unit of volatility. If you would invest 1,077 in Silver Spike Investment on August 28, 2024 and sell it today you would earn a total of 219.00 from holding Silver Spike Investment or generate 20.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 42.86% |
| Values | Daily Returns |
Supernus Pharmaceuticals vs. Silver Spike Investment
Performance |
| Timeline |
| Supernus Pharmaceuticals |
| Silver Spike Investment |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Supernus Pharmaceuticals and Silver Spike Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Supernus Pharmaceuticals and Silver Spike
The main advantage of trading using opposite Supernus Pharmaceuticals and Silver Spike positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Supernus Pharmaceuticals position performs unexpectedly, Silver Spike can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silver Spike will offset losses from the drop in Silver Spike's long position.| Supernus Pharmaceuticals vs. Prestige Brand Holdings | Supernus Pharmaceuticals vs. Evotec SE ADR | Supernus Pharmaceuticals vs. Collegium Pharmaceutical | Supernus Pharmaceuticals vs. ANI Pharmaceuticals |
| Silver Spike vs. Entourage Health Corp | Silver Spike vs. Avicanna | Silver Spike vs. Benchmark Botanics | Silver Spike vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |